EUVIMEDEUVIMED entdecken
Crossref

The Impact of Adjuvant Chemotherapy on the Long-Term Prognosis of Breast Malignant Phyllodes Tumors: A Propensity Score–Matched Study

Zilin Zhuang, Ailifeire Yilihamu, Zhihua Li, Rong Lei, Xun Li, Mengjia Han, Wei Wei, Guangxin Li, Zhen Ma, Yulu Zhang, Hui Hu, Xiaoyun Xiao und 1 weitere

Journal of the National Comprehensive Cancer Network · 2024

DOI: 10.6004/jnccn.2024.7023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024. Verfasst von Zilin Zhuang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medica…. Hauptthemen laut MEDLINE: Phyllodes Tumor, Breast Neoplasms, Propensity Score. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant phyllodes tumors (MPTs) are rare breast tumors with high risks of local recurrence and distant metastasis. Surgical intervention is the primary treatment, but the effectiveness of adjuvant therapies is uncertain. This study was designed to analyze the prognostic risk factors associated with MPTs and evaluate the efficacy of postoperative adjuvant chemotherapy. Patients and Methods: Patients who were first diagnosed with MPT without distant metastasis and received R0 resection surgery between 1999 and 2023 were included in the present study and stratified into 2 groups: chemotherapy and nonchemotherapy groups. Propensity score matching (PSM) was used to balance baseline characteristics between groups. Kaplan-Meier curves were used to estimate local recurrence–free survival (LRFS) and overall survival (OS). Cox proportional hazards analyses (univariate and multivariate) were conducted to identify prognostic risk factors.

Results

We conducted a study involving 145 patients, 31 of whom underwent a total of 12 different chemotherapy regimens following initial surgical resection. Most patients received chemotherapy regimens primarily consisting of anthracyclines, including anthracycline + ifosfamide (AI) or anthracycline + cyclophosphamide/docetaxel (AC-T) regimens. After a median follow-up of 54.5 months, 37 (25.5%) patients experienced local recurrence and 24 (16.6%) experienced distant metastasis. No significant difference was detected in the rates of local recurrence or distant metastasis between the 2 groups. Axillary lymph node positivity was the only risk factor for LRFS, whereas older age, larger tumors, axillary lymph node positivity, local recurrence, and distant metastasis were significantly associated with worse OS. Chemotherapy did not emerge as a protective factor for LRFS ( P =.501) or OS ( P =.854). After PSM, patients in the chemotherapy group did not exhibit better 5-year LRFS ( P =.934) or 5-year OS ( P =.328).

Conclusions

According to our retrospective evaluation, postoperative adjuvant chemotherapy was not associated with improved survival in patients with MPTs without distant metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phyllodes TumorBreast NeoplasmsPropensity ScoreHumansFemaleChemotherapy, AdjuvantAdultPrognosisMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesNeoplasm Recurrence, LocalYoung AdultRisk FactorsTreatment OutcomeKaplan-Meier Estimate

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen Universi…
  • Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Breast Surgery, Third Hospital of Nanchang, Nanchang, JiangXi, China.
  • Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, China.
  • The Second Affiliated Hospital of Xi'an Jiaotong University, Shan Xi, China.
  • Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Zitieren

APA

Zhuang, Z., Yilihamu, A., Li, Z., Lei, R., Li, X., Han, M., Wei, W., Li, G., Ma, Z., Zhang, Y., Hu, H., Xiao, X., & Nie, Y. (2024). The Impact of Adjuvant Chemotherapy on the Long-Term Prognosis of Breast Malignant Phyllodes Tumors: A Propensity Score–Matched Study. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2024.7023

Vancouver

Zhuang Z, Yilihamu A, Li Z, Lei R, Li X, Han M, et al. The Impact of Adjuvant Chemotherapy on the Long-Term Prognosis of Breast Malignant Phyllodes Tumors: A Propensity Score–Matched Study. Journal of the National Comprehensive Cancer Network. 2024. doi:10.6004/jnccn.2024.7023

BibTeX
@article{Zhuang2024,
  author = {Zhuang, Zilin and Yilihamu, Ailifeire and Li, Zhihua and Lei, Rong and Li, Xun and Han, Mengjia and Wei, Wei and Li, Guangxin and Ma, Zhen and Zhang, Yulu and Hu, Hui and Xiao, Xiaoyun and Nie, Yan},
  title = {The Impact of Adjuvant Chemotherapy on the Long-Term Prognosis of Breast Malignant Phyllodes Tumors: A Propensity Score–Matched Study},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  doi = {10.6004/jnccn.2024.7023}
}
Kostenlos starten →